Markets /Healthcare /CYAD Celyad Oncology S.A. CYAD Full chart Compare Add to watchlist Set alert Price alert · CYAD Alert when the price is Price abovePrice below Price level Set alert All alert types 0.47 +0.47 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2024FY 2023FY 2020 Other Income → Expenses: $34.00KOther Operating Income → Expenses: $479.00KExpenses → Selling, General & Admin: $3.20MExpenses → Research & Development: $3.31MGross Profit → Expenses: $174.00KRevenue → Gross Profit: $174.00KRevenue → Cost of Revenue: $12.00KNet Loss → Expenses: $5.82MOther Income$34.00KOther Operating Income$479.00KGross Profit$174.00KNet Loss$5.82MCost of Revenue$12.00KExpenses$6.51MSelling, General & Admin$3.20MResearch & Development$3.31MRevenue$186.00K No annual statement lines CYAD has no annual lines for this statement.
